Literature DB >> 15661835

VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise.

T Gustafsson1, H Ameln, H Fischer, C J Sundberg, J A Timmons, E Jansson.   

Abstract

VEGF-A contributes to muscle tissue angiogenesis following aerobic exercise training. The temporal response of the VEGF-A isoforms and their target receptors has not been comprehensively profiled in human skeletal muscle. We combined submaximal exercise with and without reduced leg blood flow to establish whether ischemia-induced metabolic stress was an important physiological stimuli responsible for regulating the VEGF-A system in humans. Nine healthy men performed two 45-min bouts of one-leg knee-extension exercise, with and without blood flow restriction. Muscle biopsies were obtained at rest and 2 and 6 h after exercise. Expression (mRNA) of the VEGF-A splice variants and related receptors [VEGF receptor (VEGFR)-1, VEGFR-2, and neuropilin-1] was determined by using qPCR. VEGF-A(total) expression increased more robustly after exercise with reduced blood flow, and initially this principally reflected an increase in VEGF-A(165). Six hours after exercise, there was a relatively greater increase in VEGF-A(189), and this response was not influenced by blood flow conditions. VEGFR-1 mRNA expression increased 2 h after exercise, and neuropilin-1 expression was transiently reduced, while all three receptors increased by 6 h. There was no evidence for the expression of the inhibitory VEGF-A(165B) variant in human skeletal muscle. Our study, reflecting both VEGF-A ligand and receptors, implicates metabolic perturbation as a regulator of human muscle angiogenesis and demonstrates that VEGF-A splice variants are distinctly regulated. Our findings also indicate that all three receptor genes exhibit different pretranslational regulation, in response to exercise in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661835     DOI: 10.1152/japplphysiol.01402.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  32 in total

1.  Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.

Authors:  W Schuyler Jones; Brian D Duscha; Jennifer L Robbins; Natasha N Duggan; Judith G Regensteiner; William E Kraus; William R Hiatt; Ayotunde O Dokun; Brian H Annex
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

2.  VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 3.  Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.

Authors:  Giovanni Lombardi; Veronica Sansoni; Giuseppe Banfi
Journal:  Ann Transl Med       Date:  2017-08

4.  A computational analysis of pro-angiogenic therapies for peripheral artery disease.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2018-01-22       Impact factor: 2.192

5.  Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.

Authors:  B Hoier; M Walker; M Passos; P J Walker; A Green; J Bangsbo; C D Askew; Y Hellsten
Journal:  J Appl Physiol (1985)       Date:  2013-10-24

6.  Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.

Authors:  Cleber A Trujillo; Arthur A Nery; Janaína M Alves; Antonio H Martins; Henning Ulrich
Journal:  Clin Ophthalmol       Date:  2007-12

7.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

8.  Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Physiol Genomics       Date:  2009-04-07       Impact factor: 3.107

9.  Temporal response of positive and negative regulators in response to acute and chronic exercise training in mice.

Authors:  Sara A Olenich; Navarre Gutierrez-Reed; Gerald N Audet; I Mark Olfert
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

10.  Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.

Authors:  Brad A Bryan; Tony E Walshe; Dianne C Mitchell; Josh S Havumaki; Magali Saint-Geniez; Arindel S Maharaj; Angel E Maldonado; Patricia A D'Amore
Journal:  Mol Biol Cell       Date:  2007-12-19       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.